AbolerIS Pharma

/ 1 Rue Gaston Veil
44000 Nantes
FR
AbolerIS Pharma
Foundation date
28/11/2019
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases.
Anti-CD45RC monoclonal antibody to deplete effector T cells and preserve regulatory and memory T cells.
IL-34 cytokine to induce tolerogenic macrophages/DCs and regulatory T cells.
Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Jobs
More jobs-
-
-
23/03/23
Antwerp
Postdoctoral Research Scientist – Neuroimmune Organoids in Neurodegeneration
Permanent
VIB